Guidelines

Lately pharmaceutical marketing has been under increasing attack at both state and federal governmental levels. Now Chicago has…

In a city where crime rates are sky-high and illegal drugs are easily picked up on the street, on November 16, 2016, the City of…

Recently, the Food and Drug Administration (FDA) finalized guidance detailing its approach to assigning non-proprietary names to…

The United States Food and Drug Administration (FDA) was expected to release interchangeability guidance on biosimilars sometime…

In mid-January 2017, the United States Food and Drug Administration (FDA) released a guidance document, entitled “Drug and Device…

The Department of Health and Human Services (HHS), along with fifteen other federal agencies, issued a final rule updating…

The United States Food and Drug Administration (FDA) released a new draft guidance that provides information for medical product…

The United States Food and Drug Administration (FDA) released a new draft guidance that provides information for medical product…

Clinical trials are one of the most visible components of the biomedical research field, in part due to the way they directly…

On Wednesday, July 27, 2016, the Pharmaceutical Research and Manufacturers of America (PhRMA) and the Biotechnology Innovation…